Perrigo Company News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.06.17	Perrigo Company plc Announces Pricing for its Cash Tender Offer (PR Newswire)
14.06.17	Perrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference (PR Newswire)
14.06.17	Perrigo Company plc Announces Early Tender Results for Cash Tender Offer (PR Newswire)
06.06.17	Perrigo CEO John Hendrickson To Retire (RTTNews)
05.06.17	Perrigo Announces Forthcoming Retirement Of CEO John Hendrickson (PR Newswire)
05.06.17	Perrigo Posting Notable Loss After Downgrade By RBC Capital Markets (RTTNews)
02.06.17	Perrigo Company To Present At The Jefferies 2017 Healthcare Conference (PR Newswire)
31.05.17	Perrigo Unveils $1.4 Bln Cash Tender Offer For Certain Notes (RTTNews)
31.05.17	Perrigo Company plc Announces $1,400,000,000 Cash Tender Offer for Certain Notes (PR Newswire)
30.05.17	Perrigo Co. Announces 21% Decline In Q1 Profit (RTTNews)
30.05.17	Perrigo To Conduct Conference Call On May 31, 2017 At 8:30 AM ET (PR Newswire)
30.05.17	Perrigo Company plc Files First Quarter 2017 Form 10-Q And Reports First Quarter 2017 Financial Results (PR Newswire)
23.05.17	Perrigo to Conduct Conference Call on May 23, 2017 at 8:30 AM ET (PR Newswire)
23.05.17	Perrigo Files 2016 Form 10-K With Restated Financial Statements; Reports Fourth Quarter And Calendar Year 2016 Financial Results; Announces 2017 Annual Meeting Date (PR Newswire)
08.05.17	Perrigo Announces Two New Independent Directors (PR Newswire)
08.05.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Perrigo, and BioScrip (PR Newswire)
03.05.17	Perrigo Alert: J&W Investigates Perrigo Company plc after U.S. Department of Justice Issues Search Warrants; All Investors Encouraged to Contact Firm (PR Newswire)
03.05.17	Perrigo Company plc Announces Quarterly Dividend (PR Newswire)
03.05.17	Perrigo Says Search Warrants Executed At Corporate Offices On Drug Pricing (RTTNews)
03.05.17	Perrigo Discloses Investigation (PR Newswire)
26.04.17	Perrigo To Restate Certain Financial Statements (RTTNews)
25.04.17	Perrigo Announces Restatement Of Previously Issued Forms 10-K And 10-Q Financial Statements; Announces Select Preliminary Unaudited First Quarter 2017 Financial Results (PR Newswire)
27.03.17	Perrigo Completes Divestiture Of Tysabri® Royalty Stream For Up To $2.85 Billion (PR Newswire)
25.03.17	Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander... (PR Newswire)
24.03.17	How These Healthcare Stocks are Faring? -- BioScrip, Community Health Systems, Perrigo, and Health Insurance Innovations (PR Newswire)
16.03.17	Perrigo Provides Update On 2016 Form 10-K Filing (PR Newswire)
08.03.17	Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine® Foam (PR Newswire)
07.03.17	Perrigo Provides 2016 Form 10-K Update (PR Newswire)
01.03.17	Covered Call reports for 3D Systems, Metlife Incorporated, Pandora, Perrigo Co. and ZTO Express include trade ideas that offer returns of 21% or more! (PR Newswire)
01.03.17	Perrigo Gets FDA Approval For Generic Version Of Axiron Topical Solution (RTTNews)
01.03.17	Perrigo Announces FDA Final Approval For The Generic Version Of Axiron® Topical Solution, 30 mg/1.5 mL (PR Newswire)
01.03.17	Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO... (RTTNews)
28.02.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Perrigo Company plc (PRGO) (PR Newswire)
27.02.17	Perrigo Expects FY16 Adj. EPS In Range Of $7.10 - $7.25 - Quick Facts (RTTNews)
27.02.17	Perrigo To Divest Its Rights To Royalty Stream From Tysabri To Royalty Pharma (RTTNews)
27.02.17	Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2016 Financial Results And Initial Calendar Year 2017 Guidance (PR Newswire)
27.02.17	Perrigo Signs Agreement To Divest Tysabri® Royalty Stream For Up To $2.85 Billion (PR Newswire)
27.02.17	Perrigo Announces Leadership Changes (PR Newswire)
21.02.17	Perrigo Company plc Announces Quarterly Dividend (PR Newswire)
17.02.17	Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution (PR Newswire)
14.02.17	Perrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 (PR Newswire)
07.02.17	Perrigo Confirms Patent Challenge For Generic Version Of Onexton® Gel (PR Newswire)
07.02.17	Perrigo Announces Agreement With Starboard (PR Newswire)
24.01.17	Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25% (PR Newswire)
11.01.17	Research Reports Coverage on Healthcare Stocks -- Perrigo, Bruker, ICON, and HTG Molecular Diagnostics (PR Newswire)
10.01.17	Perrigo Updates Segment Reporting Structure (PR Newswire)
20.12.16	Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette® White Ice Mint® Gum (PR Newswire)
22.11.16	Research Reports Initiation on Healthcare Stocks -- Perrigo, Pacira Pharma, Supernus Pharma, and PerkinElmer (PR Newswire)
25.09.15	Mylan Says Perrigo's Lawsuit Entirely Without Merit; Offer Valid And Proper (RTTNews)
22.09.15	Perrigo Announces Launch Of AB Rated Generic Version Of BenzaClin Topical Gel (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’275.00	0.63 %	K V
Logitech Intl	75.14	0.37 %	K V
Alcon	76.50	0.24 %	K V
Holcim	89.06	0.23 %	K V
Kuehne+Nagel Int	203.00	0.20 %	K V
Swisscom	502.50	-0.89 %	K V
Sika	223.90	-1.02 %	K V
Swiss Re	130.00	-1.48 %	K V
Givaudan	3’995.00	-1.63 %	K V
Nestle	73.90	-1.75 %	K V

mehr

21.10.24		S&P 500 aktuell: S&P 500 gibt nach
30.09.24		Handel in New York: S&P 500 fällt nachmittags
09.08.24		Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge
09.08.24		Gewinne in New York: S&P 500-Börsianer greifen zu
09.08.24		Verluste in New York: S&P 500 fällt am Mittag zurück
06.08.24		Pluszeichen in New York: S&P 500 mittags fester
05.08.24		Handel in New York: S&P 500 verbucht schlussendlich Verluste
11.06.24		Pluszeichen in New York: S&P 500 legt schlussendlich zu

21.10.24

S&P 500 aktuell: S&P 500 gibt nach

30.09.24

Handel in New York: S&P 500 fällt nachmittags

09.08.24

Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge

09.08.24

Gewinne in New York: S&P 500-Börsianer greifen zu

09.08.24

Verluste in New York: S&P 500 fällt am Mittag zurück

06.08.24

Pluszeichen in New York: S&P 500 mittags fester